New case: Gut microbiota & Non-Alcoholic Fatty Liver Disease
An article, recently published in Nature, unveils a promising pathway in the fight against smoking-related Non-Alcoholic Fatty Liver Disease.
Dive into the details:
The study reveals how gut bacteria could hold the key to alleviating NAFLD by degrading nicotine found in the intestine. Nicotine accumulation during smoking activates intestinal AMPKα, a key player in cellular energy regulation. But here’s the twist: the research identified Bacteroides xylanisolvens as a potent nicotine degrader, offering a new perspective on combating NAFLD.
What does this mean?
The findings underscore the significance of gut microbiota in NAFLD progression and suggest potential interventions to reduce tobacco smoking-exacerbated NAFLD severity.
BMKGENE contributed in providing sequencing and analysis services, enabling this groundbreaking discovery.
If you would like to learn more about this study, access this link. For more information on our sequencing and bioinformatics services, you can talk to us here.
Post time: Jul-16-2024